Gene expression profile of cervical and skin tissues from human papillomavirus type 16 E6 transgenic mice

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Mendoza Villanueva, D ^a   Diaz Chavez, J ^a   Uribe Figueroa, L ^b   Rangel Escareao C ^b   Hidalgo Miranda, A ^b   March Mifsut, S ^b   Jimenez Sanchez, G ^b   Lambert, P F ^c   Gariglio, P ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E6; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; REPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL JUNCTION; CONTROLLED STUDY; EPIDERMIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; HOST RESISTANCE; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNE RESPONSE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SKIN; STATISTICAL MODEL; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; UTERINE CERVIX; VIRUS INFECTION; ANIMAL; DNA MICROARRAY; GENETICS; IN SITU HYBRIDIZATION; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY;

ANIMALS; CERVIX UTERI; FEMALE; GENE EXPRESSION PROFILING; HUMAN PAPILLOMAVIRUS 16; IN SITU HYBRIDIZATION; MICE; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN;

EID: 58149093806     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-347     Document Type: Article

References (66)

1. zur Hausen H Papillomavirus infections - a major cause of human cancers Biochim Biophys Acta 1996, 1288:F55-78 8876633
2. Bahnassy AA Zekri AR Saleh M Lotayef M Moneir M Shawki O The possible role of cell cycle regulators in multistep process of HPV-associated cervical carcinoma BMC Clin Pathol 2007, 7:4 1894982 17521451 10.1186/ 1472-6890-7-4
3. Woodworth CD Doniger J DiPaolo JA Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma J Virol 1989, 63:159-164 247668 2462058
4. Brule van den AJ Cromme FV Snijders PJ Smit L Oudejans CB Baak JP Meijer CJ Walboomers JM Nonradioactive RNA in situ hybridization detection of human papillomavirus 16-E7 transcripts in squamous cell carcinomas of the uterine cervix using confocal laser scan microscopy Am J Pathol 1991, 139:1037-1045 1886338 1719818
5. Munger K Phelps WC Bubb V Howley PM Schlegel R The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes J Virol 1989, 63:4417-4421 251060 2476573
6. Sedman SA Hubbert NL Vass WC Lowy DR Schiller JT Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity J Virol 1992, 66:4201-4208 241223 1318401
7. Bedell MA Jones KH Grossman SR Laimins LA Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells J Virol 1989, 63:1247-1255 247821 2536832
8. Phelps WC Yee CL Munger K Howley PM The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A Cell 1988, 53:539-547 10.1016/ 0092-8674(88)90570-3 2836062
9. Storey A Pim D Murray A Osborn K Banks L Crawford L Comparison of the in vitro transforming activities of human papillomavirus types Embo J 1988, 7:1815-1820 457173 2458921
10. Storey A Banks L Human papillomavirus type 16 E6 gene cooperates with EJ-ras to immortalize primary mouse cells Oncogene 1993, 8:919-924 8384359
11. Werness BA Levine AJ Howley PM Association of human papillomavirus types 16 and 18 E6 proteins with p53 Science 1990, 248:76-79 10.1126/ science.2157286 2157286
12. Heck DV Yee CL Howley PM Munger K Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses Proc Natl Acad Sci USA 1992, 89:4442-4446 49098 1316608 10.1073/pnas.89.10.4442
13. Nakagawa S Watanabe S Yoshikawa H Taketani Y Yoshiike K Kanda T Mutational analysis of human papillomavirus type 16 E6 protein: transforming function for human cells and degradation of p53 in vitro Virology 1995, 212:535-542 10.1006/viro.1995.1511 7571423
14. Mansur CP Androphy EJ Cellular transformation by papillomavirus oncoproteins Biochim Biophys Acta 1993, 1155:323-345 8268190
15. Song S Pitot HC Lambert PF The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals J Virol 1999, 73:5887-5893 112649 10364340
16. Herber R Liem A Pitot H Lambert PF Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene J Virol 1996, 70:1873-1881 190015 8627712
17. Song S Liem A Miller JA Lambert PF Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis Virology 2000, 267:141-150 10.1006/viro.1999.0106 10662610
18. Arbeit JM Howley PM Hanahan D Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice Proc Natl Acad Sci USA 1996, 93:2930-2935 39737 8610145 10.1073/pnas.93.7.2930
19. Elson DA Riley RR Lacey A Thordarson G Talamantes FJ Arbeit JM Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis Cancer Res 2000, 60:1267-1275 10728686
20. Riley RR Duensing S Brake T Munger K Lambert PF Arbeit JM Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis Cancer Res 2003, 63:4862-4871 12941807
21. Brake T Lambert PF Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model Proc Natl Acad Sci USA 2005, 102:2490-2495 548999 15699322 10.1073/pnas.0409883102
22. Shai A Brake T Somoza C Lambert PF The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities Cancer Res 2007, 67:1626-1635 10.1158/ 0008-5472.CAN-06-3344 17308103
23. Shai A Pitot HC Lambert PF p53 Loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancers Cancer Res 2008, 68:2622-2631 10.1158/0008-5472.CAN-07-5266 18413729
24. Liu Y Chen JJ Gao Q Dalal S Hong Y Mansur CP Band V Androphy EJ Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells J Virol 1999, 73:7297-7307 104255 10438818
25. Kiyono T Foster SA Koop JI McDougall JK Galloway DA Klingelhutz AJ Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells Nature 1998, 396:84-88 10.1038/23962 9817205
26. Kiyono T Hiraiwa A Fujita M Hayashi Y Akiyama T Ishibashi M Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein Proc Natl Acad Sci USA 1997, 94:11612-11616 23554 9326658 10.1073/pnas.94.21.11612
27. Nguyen M Song S Liem A Androphy E Liu Y Lambert PF A mutant of human papillomavirus type 16 E6 deficient in binding alpha-helix partners displays reduced oncogenic potential in vivo J Virol 2002, 76:13039-13048 136691 12438630 10.1128/JVI.76.24.13039-13048.2002
28. Elbel M Carl S Spaderna S Iftner T A comparative analysis of the interactions of the E6 proteins from cutaneous and genital papillomaviruses with p53 and E6AP in correlation to their transforming potential Virology 1997, 239:132-149 10.1006/viro.1997.8860 9426453
29. Zhang Y Dasgupta J Ma RZ Banks L Thomas M Chen XS Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: Mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein J Virol 2007, 81:3618-3626 1866053 17267502 10.1128/JVI.02044-06
30. Simonson SJ Difilippantonio MJ Lambert PF Two distinct activities contribute to human papillomavirus 16 E6′s oncogenic potential Cancer Res 2005, 65:8266-8273 10.1158/0008-5472.CAN-05-1651 16166303
31. Bolstad BM Irizarry RA Astrand M Speed TP A comparison of normalization methods for high density oligonucleotide array data based on variance and bias Bioinformatics 2003, 19:185-193 10.1093/bioinformatics/19.2.185 12538238
32. Smyth GK Linear models and empirical bayes methods for assessing differential expression in microarray experiments Stat Appl Genet Mol Biol 2004:3 16646809
33. Dahlquist KD Salomonis N Vranizan K Lawlor SC Conklin BR GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways Nat Genet 2002, 31:19-20 10.1038/ng0502-19 11984561
34. Livak KJ Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 2001, 25:402-408 10.1006/meth.2001.1262 11846609
35. Yalcin A Quantification of thioredoxin mRNA expression in the rat hippocampus by real-time PCR following oxidative stress Acta Biochim Pol 2004, 51:1059-1065 15625578
36. Lanham S Herbert A Watt P HPV detection and measurement of HPV-16, telomerase, and survivin transcripts in colposcopy clinic patients J Clin Pathol 2001, 54:304-308 1731406 11304848 10.1136/jcp.54.4.304
37. Pan H Griep AE Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: Implications for tumor suppressor gene function in development Genes Dev 1994, 8:1285-1299 10.1101/gad.8.11.1285 7926731
38. King RW Jackson PK Kirschner MW Mitosis in transition Cell 1994, 79:563-571 10.1016/0092-8674(94)90542-8 7954823
39. Finn OJ Premalignant lesions as targets for cancer vaccines J Exp Med 2003, 198:1623-1626 2194136 14638849 10.1084/jem.20031787
40. Yu M Zhan Q Finn OJ Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53 Mol Immunol 2002, 38:981-987 10.1016/ S0161-5890(02)00026-3 12009577
41. Tachibana KE Gonzalez MA Coleman N Cell-cycle-dependent regulation of DNA replication and its relevance to cancer pathology J Pathol 2005, 205:123-129 10.1002/path.1708 15643673
42. Erlandsson F Martinsson-Ahlzen HS Wallin KL Hellstrom AC Andersson S Zetterberg A Parallel cyclin E and cyclin A expression in neoplastic lesions of the uterine cervix Br J Cancer 2006, 94:1045-1050 10.1038/ sj.bjc.6603038 16538218
43. Clark KL Halay ED Lai E Burley SK Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5 Nature 1993, 364:412-420 10.1038/364412a0 8332212
44. Korver W Roose J Clevers H The winged-helix transcription factor Trident is expressed in cycling cells Nucleic Acids Res 1997, 25:1715-1719 146663 9108152 10.1093/nar/25.9.1715
45. Yao KM Sha M Lu Z Wong GG Molecular analysis of a novel winged helix protein, WIN. Expression pattern, DNA binding property, and alternative splicing within the DNA binding domain J Biol Chem 1997, 272:19827-19836 10.1074/jbc.272.32.19827 9242644
46. Ye H Kelly TF Samadani U Lim L Rubio S Overdier DG Roebuck KA Costa RH Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues Mol Cell Biol 1997, 17:1626-1641 231888 9032290
47. Teh MT Wong ST Neill GW Ghali LR Philpott MP Quinn AG FOXM1 is a downstream target of Gli1 in basal cell carcinomas Cancer Res 2002, 62:4773-4780 12183437
48. Pommier Y DNA topoisomerase I and II in cancer chemotherapy: Update and perspectives Cancer Chemother Pharmacol 1993, 32:103-108 10.1007/ BF00685611 8387398
49. Santin AD Zhan F Bignotti E Siegel ER Cane S Bellone S Palmieri M Anfossi S Thomas M Burnett A et al. Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: Identification of novel candidate molecular markers for cervical cancer diagnosis and therapy Virology 2005, 331:269-291 10.1016/j.virol.2004.09.045 15629771
50. Pyeon D Newton MA Lambert PF den Boon JA Sengupta S Marsit CJ Woodworth CD Connor JP Haugen TH Smith EM et al. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers Cancer Res 2007, 67:4605-4619 10.1158/0008-5472.CAN-06-3619 17510386
51. Zornig M Hueber A Baum W Evan G Apoptosis regulators and their role in tumorigenesis Biochim Biophys Acta 2001, 1551:F1-37 11591448
52. Philchenkov A Caspases: Potential targets for regulating cell death J Cell Mol Med 2004, 8:432-444 10.1111/j.1582-4934.2004.tb00468.x 15601572
53. Nair P Nair KM Jayaprakash PG Pillai MR Decreased programmed cell death in the uterine cervix associated with high risk human papillomavirus infection Pathol Oncol Res 1999, 5:95-103 10.1053/paor.1999.0161 10393359
54. Aguilar-Lemarroy A Kirchhoff S Whitaker N Gariglio P zur Hausen H Krammer PH Rosl F Differential sensitivity of human papillomavirus type 16(+) and type 18(+) cervical carcinoma cells to CD95-mediated apoptosis Int J Cancer 2001, 93:823-831 10.1002/ijc.1405 11519044
55. Hougardy BM Zee van der AG Heuvel van den FA Timmer T de Vries EG de Jong S Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: Relationship with Fas, caspase-8, and Bid Gynecol Oncol 2005, 97:353-364 10.1016/j.ygyno.2005.01.036 15863130
56. Parmar S Platanias LC Interferons: Mechanisms of action and clinical applications Curr Opin Oncol 2003, 15:431-439 10.1097/ 00001622-200311000-00005 14624225
57. Ronco LV Karpova AY Vidal M Howley PM Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity Genes Dev 1998, 12:2061-2072 316980 9649509 10.1101/gad.12.13.2061
58. Chang YE Laimins LA Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31 J Virol 2000, 74:4174-4182 111932 10756030 10.1128/JVI.74.9.4174-4182.2000
59. Nees M Geoghegan JM Hyman T Frank S Miller L Woodworth CD Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes J Virol 2001, 75:4283-4296 114174 11287578 10.1128/JVI.75.9.4283-4296.2001
60. Sherman L Schlegel R Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16 J Virol 1996, 70:3269-3279 190193 8627810
61. Nees M Geoghegan JM Munson P Prabhu V Liu Y Androphy E Woodworth CD Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes Cancer Res 2000, 60:4289-4298 10945644
62. Duffy CL Phillips SL Klingelhutz AJ Microarray analysis identifies differentiation-associated genes regulated by human papillomavirus type 16 E6 Virology 2003, 314:196-205 10.1016/S0042-6822(03)00390-8 14517073
63. Yim EK Meoyng J Namakoong SE Um SJ Park JS Genomic and proteomic expression patterns in HPV-16 E6 gene transfected stable human carcinoma cell lines DNA Cell Biol 2004, 23:826-835 10.1089/dna.2004.23.826 15684709
64. Gius D Funk MC Chuang EY Feng S Huettner PC Nguyen L Bradbury CM Mishra M Gao S Buttin BM et al. Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates Cancer Res 2007, 67:7113-7123 10.1158/ 0008-5472.CAN-07-0260 17671178
65. Harris TG Kulasingam SL Kiviat NB Mao C Agoff SN Feng Q Koutsky LA Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia Am J Epidemiol 2004, 159:834-842 10.1093/aje/kwh115 15105176
66. Rieck G Fiander A The effect of lifestyle factors on gynaecological cancer Best Pract Res Clin Obstet Gynaecol 2006, 20:227-251 10.1016/ j.bpobgyn.2005.10.010 16543119